Regulations.gov document
FDA/CDER Response to Amphastar Pharmaceuticals, Inc. (C2) - Letter
Other · FDA-2003-P-0273 · posted Apr 22, 2009
Key facts
| Document ID | FDA-2003-P-0273-0012 |
|---|---|
| Title | FDA/CDER Response to Amphastar Pharmaceuticals, Inc. (C2) - Letter |
| Document type | Other |
| Subtype | ANS-Answer |
| Agency | FDA |
| Docket | FDA-2003-P-0273 |
| Posted | Apr 22, 2009 |
| Comment period opens | Apr 22, 2009 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: